-
Report Details
More...Snapshot
The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to -
Table Of Content
More...
Table of Content
1 Industry Overview
1.1 Iron Chelation Drug Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Iron Chelation Drug Market by Type
2.1 By Type
2.1.1 Deferoxamine
2.1.2 Deferiprone
2.1.3 Deferasirox
2.2 Market -
Inquiry Before Buying
-
Request Sample
